Abstract:<h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Ethnopharmacological relevance</h3><p><em>Fructus Ligustri Lucidi</em> (FLL) is an edible herb with anti-osteoporotic activity, yet whether and how the aqueous extract of this herb affect calcium metabolism in preservation of bone quality remain unclear.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Aim of the study</h3><p>To investigate the effects of FLL aqueous extract on calcium balance and short-chain fatty acids (SCFAs) production in ovariectomized (OVX) rats.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Materials and methods</h3><p>OVX rats were daily and orally administrated with FLL aqueous extract (3.5 g/kg) for 14 weeks. The levels of N-terminal propeptide of type I collagen (PINP) and C-terminal telopeptide of type I collagen (CTx-I) in rat serum were evaluated by ELISA assays. The concentration of calcium in serum, urine, and feces were determined by biochemical assays. Bone quality was determined by Micro-CT, a three-point bending assay, and Fourier Transform Infrared (FTIR) Spectrometry. The expressions of Calbindin D28K and Calcium-sensing receptor (CaSR) in kidney as well as the Vitamin D receptor (VDR), the transient receptor potential vanilloid receptor 6 (TRPV6), Calbindin D9k in the duodenum were measured by immunohistochemistry, western blotting, or real-time PCR. The short-chain fatty acids (SCFAs) levels in the feces of the cecum were tested by gas chromatograghy.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Results</h3><p>The administration of FLL to OVX rats resulted in a significant improvement in bone mineral density and biomechanical strength as well as in maintaining bone microstructures and material quality. Meanwhile, the decreased levels of PINP and increased levels of CTx-I in OVX rats were restored by FLL treatment. Additionally, FLL treatment increased calcium absorption, upregulated VDR, TRPV6, Calbindin D9k expressions in the duodenum, Calbindin D28K in kidney, and down-regulated CaSR expression in the kidney, as well as enhanced SCFAs levels in the feces of OVX rats.</p><h3 class="u-h4 u-margin-m-top u-margin-xs-bottom">Conclusions</h3><p>FLL aqueous extract may preserve bone quality through regulation of the calcium balance and intestinal SCFAs production in OVX rats. This offers translational value of FLL into osteoporosis clinical trial.</p>

Osteolytic activity and reversal of nephrectomy-induced hypocalcemia by a fraction other than 1,25(OH)2-vitamin D3 from Solanum malacoxylon incubated with ruminal fluid

Modification by rumen of vitamin D-like activity of Solanum malacoxylon in rats

Effect of 1,25-(OH)2 D3 on the expression of amelogenin and ameloblastin secreted by porcine ameloblasts

[Effect of the Bone Resorption Supernatant from RAW264.7 Osteoclast on the Osteogenic Activity of Mouse MC3T3-E1 Cell].

Effects of 1alpha,25-dihydroxyvitamin D3 and Solanum glaucophyllum on intestinal calcium and phosphate transport and on plasma Ca, Mg and P levels in the rat.

Effects of 1a,25-Dihydroxyvitamin D3-26,23-Lactone and Its Intermediate Metabolites on Bone Metabolism in vivo and in vitro

Histochemical examination of the effects of high-dose 1,25(OH)2D3 on bone remodeling in young growing rats

New Insights into Mechanisms Of Vitamin D Action Revealed Through The Study Of Transgenic, Knockout, and Aging Mice

In vitro synthesis of 1 alpha,25-dihydroxycholecalciferol and 24,25-dihydroxycholecalciferol by isolated calvarial cells

Eldecalcitol, a vitamin D analog, reduces bone turnover and increases trabecular and cortical bone mass, density, and strength in ovariectomized cynomolgus monkeys

Action of 1,25-dihydroxyvitamin D3 and a diphosphonate on calcium metabolism in rats

Changes of 1,25 Dihydroxyvitamin D Levels in OVX Female Rats after Nilestriol Treatment

An Evaluation of 1a-Hydroxy-and 1,25-Dihydroxyvitamin D3 in the Treatment of Renal Bone Disease

1,25-Dihydroxycholecalciferol in Dialysed Patients with Clinically Asymptomatic Renal Osteodystrophy A Controlled Study1

Experimental Testing of the Action of Vitamin D and Silicon Chelates in Bone Fracture Healing and Bone Turnover in Mice and Rats

The Effect of 1,25 (OH)2D3 on Bone Mineralization: Ultrastructural Studies in Patients with Renal Osteodystrophy

The Action of 1,25 (OH)2D3 on Turnover Kinetic, Remodelling Surfaces and Structure of Trabecular Bone in Chronic Renal Failure

Analysis of 1,25-Dihydroxyvitamin D3 Genomic Action Reveals Calcium-Regulating and Calcium-Independent Effects in Mouse Intestine and Human Enteroids

Bone Fracture-healing Properties and UPLC-MS Analysis of an Enriched Flavonoid Fraction from Oxystelma esculentum

Identification of 1,24(R)-dihydroxyvitamin D3-like bone-resorbing lipid in a patient with cancer-associated hypercalcemia

Fructus Ligustri Lucidi aqueous extract promotes calcium balance and short-chain fatty acids production in ovariectomized rats